nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—CA9—kidney cancer	0.365	0.398	CbGaD
Sulpiride—CA2—kidney cancer	0.328	0.358	CbGaD
Sulpiride—BCHE—kidney cancer	0.223	0.244	CbGaD
Sulpiride—CA2—collecting duct of renal tubule—kidney cancer	0.0036	0.518	CbGeAlD
Sulpiride—CA12—renal system—kidney cancer	0.000612	0.0881	CbGeAlD
Sulpiride—CA12—kidney—kidney cancer	0.000592	0.0852	CbGeAlD
Sulpiride—CA2—nephron tubule—kidney cancer	0.000346	0.0498	CbGeAlD
Sulpiride—BCHE—nephron tubule—kidney cancer	0.000331	0.0477	CbGeAlD
Sulpiride—CA2—renal system—kidney cancer	0.000314	0.0453	CbGeAlD
Sulpiride—CA2—kidney—kidney cancer	0.000304	0.0438	CbGeAlD
Sulpiride—CA2—cortex of kidney—kidney cancer	0.000296	0.0426	CbGeAlD
Sulpiride—CA2—cardiac atrium—kidney cancer	0.000282	0.0405	CbGeAlD
Sulpiride—BCHE—cardiac atrium—kidney cancer	0.00027	0.0388	CbGeAlD
Sulpiride—CA12—Metabolism—BCHE—kidney cancer	6.01e-05	0.000778	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—JUN—kidney cancer	5.97e-05	0.000773	CbGpPWpGaD
Sulpiride—CA12—Metabolism—SLC5A5—kidney cancer	5.93e-05	0.000769	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—RPL14—kidney cancer	5.85e-05	0.000758	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—HSPD1—kidney cancer	5.85e-05	0.000758	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ITPR2—kidney cancer	5.78e-05	0.000749	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—BRAF—kidney cancer	5.73e-05	0.000743	CbGpPWpGaD
Sulpiride—CA12—Metabolism—SLC2A1—kidney cancer	5.73e-05	0.000742	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LATS1—kidney cancer	5.66e-05	0.000733	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.59e-05	0.000724	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GSTP1—kidney cancer	5.53e-05	0.000716	CbGpPWpGaD
Sulpiride—BCHE—Phospholipid metabolism—PTEN—kidney cancer	5.43e-05	0.000704	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GLIPR1—kidney cancer	5.36e-05	0.000694	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PPAT—kidney cancer	5.36e-05	0.000694	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.29e-05	0.000685	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GSTT1—kidney cancer	5.27e-05	0.000683	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ACHE—kidney cancer	5.27e-05	0.000683	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—POMC—kidney cancer	5.26e-05	0.000681	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CRABP1—kidney cancer	5.24e-05	0.000679	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.24e-05	0.000678	CbGpPWpGaD
Sulpiride—CA6—Metabolism—ABCB1—kidney cancer	5.23e-05	0.000678	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—VEGFA—kidney cancer	5.22e-05	0.000676	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—AKAP13—kidney cancer	5.15e-05	0.000667	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—OR4C13—kidney cancer	5.09e-05	0.00066	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GSTM1—kidney cancer	5.08e-05	0.000658	CbGpPWpGaD
Sulpiride—CA2—Metabolism—SCARB1—kidney cancer	4.99e-05	0.000646	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—APRT—kidney cancer	4.98e-05	0.000645	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—FH—kidney cancer	4.98e-05	0.000645	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—ANXA1—kidney cancer	4.97e-05	0.000644	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PTGS1—kidney cancer	4.94e-05	0.00064	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—MAPK3—kidney cancer	4.93e-05	0.000639	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ITPR2—kidney cancer	4.87e-05	0.000631	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PSMD7—kidney cancer	4.84e-05	0.000627	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—ACHE—kidney cancer	4.83e-05	0.000625	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CYP1A1—kidney cancer	4.81e-05	0.000624	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AMER1—kidney cancer	4.81e-05	0.000623	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	4.79e-05	0.00062	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GSTP1—kidney cancer	4.78e-05	0.000619	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	4.77e-05	0.000618	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—MAPK1—kidney cancer	4.7e-05	0.000608	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GPC3—kidney cancer	4.68e-05	0.000606	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—AKAP13—kidney cancer	4.68e-05	0.000606	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—PAX6—kidney cancer	4.59e-05	0.000595	CbGpPWpGaD
Sulpiride—CA2—Metabolism—BCHE—kidney cancer	4.59e-05	0.000595	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—CTSD—kidney cancer	4.57e-05	0.000592	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CA2—kidney cancer	4.55e-05	0.00059	CbGpPWpGaD
Sulpiride—CA2—Metabolism—SLC5A5—kidney cancer	4.54e-05	0.000588	CbGpPWpGaD
Sulpiride—CA12—Metabolism—ABCB1—kidney cancer	4.52e-05	0.000586	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GSTT1—kidney cancer	4.44e-05	0.000576	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ACHE—kidney cancer	4.44e-05	0.000576	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ALAD—kidney cancer	4.44e-05	0.000575	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—BRAF—kidney cancer	4.39e-05	0.000569	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GSTM1—kidney cancer	4.39e-05	0.000569	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ITPR2—kidney cancer	4.38e-05	0.000567	CbGpPWpGaD
Sulpiride—CA2—Metabolism—SLC2A1—kidney cancer	4.38e-05	0.000567	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ST3GAL2—kidney cancer	4.33e-05	0.000561	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LATS1—kidney cancer	4.33e-05	0.000561	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—JUN—kidney cancer	4.28e-05	0.000555	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ALDH1A1—kidney cancer	4.23e-05	0.000548	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SCARB1—kidney cancer	4.21e-05	0.000545	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	4.18e-05	0.000541	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PTGS1—kidney cancer	4.16e-05	0.000539	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CYP1A1—kidney cancer	4.16e-05	0.000539	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—PTEN—kidney cancer	4.14e-05	0.000537	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PSMD7—kidney cancer	4.08e-05	0.000529	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PGK1—kidney cancer	4.06e-05	0.000526	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC5A3—kidney cancer	4.06e-05	0.000526	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GPC3—kidney cancer	4.03e-05	0.000522	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CER1—kidney cancer	4.03e-05	0.000522	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—POMC—kidney cancer	4.02e-05	0.000521	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—LDHB—kidney cancer	3.98e-05	0.000516	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ITPR2—kidney cancer	3.98e-05	0.000515	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—AKAP13—kidney cancer	3.94e-05	0.000511	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—TP53—kidney cancer	3.94e-05	0.000511	CbGpPWpGaD
Sulpiride—CA9—Metabolism—BCHE—kidney cancer	3.87e-05	0.000501	CbGpPWpGaD
Sulpiride—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	3.83e-05	0.000497	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SLC5A5—kidney cancer	3.82e-05	0.000495	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SLC2A1—kidney cancer	3.69e-05	0.000478	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AMER1—kidney cancer	3.68e-05	0.000477	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ANXA1—kidney cancer	3.67e-05	0.000476	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—RAF1—kidney cancer	3.67e-05	0.000475	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GSTP1—kidney cancer	3.65e-05	0.000473	CbGpPWpGaD
Sulpiride—CA6—Metabolism—POMC—kidney cancer	3.59e-05	0.000465	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—AKAP13—kidney cancer	3.58e-05	0.000464	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ABCB1—kidney cancer	3.46e-05	0.000448	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CA9—kidney cancer	3.45e-05	0.000447	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SFRP2—kidney cancer	3.43e-05	0.000444	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.37e-05	0.000437	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GSTM1—kidney cancer	3.36e-05	0.000435	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ITPR2—kidney cancer	3.35e-05	0.000434	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ANXA1—kidney cancer	3.33e-05	0.000432	CbGpPWpGaD
Sulpiride—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.28e-05	0.000425	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—JUN—kidney cancer	3.28e-05	0.000425	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—IGF2—kidney cancer	3.26e-05	0.000422	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	3.2e-05	0.000414	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP1A1—kidney cancer	3.18e-05	0.000412	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—POMC—kidney cancer	3.18e-05	0.000412	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—PTEN—kidney cancer	3.17e-05	0.000411	CbGpPWpGaD
Sulpiride—CA12—Metabolism—POMC—kidney cancer	3.1e-05	0.000402	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GPC3—kidney cancer	3.09e-05	0.0004	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CER1—kidney cancer	3.09e-05	0.0004	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GSTP1—kidney cancer	3.08e-05	0.000399	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ITPR2—kidney cancer	3.04e-05	0.000394	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CRABP1—kidney cancer	2.94e-05	0.00038	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ABCB1—kidney cancer	2.92e-05	0.000378	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PTGS2—kidney cancer	2.86e-05	0.000371	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GSTM1—kidney cancer	2.83e-05	0.000367	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—TP53—kidney cancer	2.83e-05	0.000366	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ANXA1—kidney cancer	2.81e-05	0.000364	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKAP13—kidney cancer	2.76e-05	0.000358	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CASP2—kidney cancer	2.76e-05	0.000358	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ITPR2—kidney cancer	2.73e-05	0.000353	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP1A1—kidney cancer	2.68e-05	0.000348	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SFRP2—kidney cancer	2.62e-05	0.00034	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ANXA1—kidney cancer	2.55e-05	0.00033	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GRB7—kidney cancer	2.53e-05	0.000327	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—MAPK1—kidney cancer	2.52e-05	0.000326	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.52e-05	0.000326	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PTEN—kidney cancer	2.5e-05	0.000323	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ACHE—kidney cancer	2.49e-05	0.000322	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTT1—kidney cancer	2.49e-05	0.000322	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PTGS2—kidney cancer	2.48e-05	0.000321	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—POMC—kidney cancer	2.44e-05	0.000315	CbGpPWpGaD
Sulpiride—CA2—Metabolism—POMC—kidney cancer	2.37e-05	0.000307	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SCARB1—kidney cancer	2.36e-05	0.000305	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ITPR2—kidney cancer	2.35e-05	0.000304	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PTGS1—kidney cancer	2.33e-05	0.000302	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PSMD7—kidney cancer	2.29e-05	0.000296	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—POMC—kidney cancer	2.17e-05	0.000282	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—TP53—kidney cancer	2.16e-05	0.00028	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PTEN—kidney cancer	2.16e-05	0.00028	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC5A5—kidney cancer	2.14e-05	0.000277	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CTNNA1—kidney cancer	2.13e-05	0.000276	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HSPB1—kidney cancer	2.12e-05	0.000274	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EIF4EBP1—kidney cancer	2.12e-05	0.000274	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CASP2—kidney cancer	2.12e-05	0.000274	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKAP13—kidney cancer	2.12e-05	0.000274	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC2A1—kidney cancer	2.07e-05	0.000268	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.01e-05	0.00026	CbGpPWpGaD
Sulpiride—CA9—Metabolism—POMC—kidney cancer	2e-05	0.000259	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PSMD7—kidney cancer	1.97e-05	0.000255	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ANXA1—kidney cancer	1.97e-05	0.000255	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TSC1—kidney cancer	1.97e-05	0.000255	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GRB7—kidney cancer	1.93e-05	0.000251	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FLT1—kidney cancer	1.91e-05	0.000247	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PTGS2—kidney cancer	1.89e-05	0.000245	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—POMC—kidney cancer	1.8e-05	0.000233	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ITPR2—kidney cancer	1.8e-05	0.000233	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PAK1—kidney cancer	1.77e-05	0.000229	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—JUNB—kidney cancer	1.77e-05	0.000229	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PIK3CA—kidney cancer	1.76e-05	0.000228	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.75e-05	0.000227	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTP1—kidney cancer	1.72e-05	0.000223	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PTEN—kidney cancer	1.65e-05	0.000214	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—POMC—kidney cancer	1.63e-05	0.000212	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ABCB1—kidney cancer	1.63e-05	0.000211	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CTNNA1—kidney cancer	1.63e-05	0.000211	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HSPB1—kidney cancer	1.62e-05	0.00021	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EIF4EBP1—kidney cancer	1.62e-05	0.00021	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PTGS2—kidney cancer	1.6e-05	0.000207	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTM1—kidney cancer	1.59e-05	0.000205	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	1.55e-05	0.000201	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PIK3CA—kidney cancer	1.52e-05	0.000197	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PSMD7—kidney cancer	1.51e-05	0.000195	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TSC1—kidney cancer	1.51e-05	0.000195	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ANXA1—kidney cancer	1.51e-05	0.000195	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP1A1—kidney cancer	1.5e-05	0.000195	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FLT1—kidney cancer	1.46e-05	0.000189	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF2—kidney cancer	1.45e-05	0.000187	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CDKN2B—kidney cancer	1.44e-05	0.000186	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF1R—kidney cancer	1.4e-05	0.000181	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PTEN—kidney cancer	1.39e-05	0.00018	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—POMC—kidney cancer	1.38e-05	0.000178	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PAK1—kidney cancer	1.35e-05	0.000175	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—JUNB—kidney cancer	1.35e-05	0.000175	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—RAF1—kidney cancer	1.35e-05	0.000174	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—IL2—kidney cancer	1.33e-05	0.000172	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—POMC—kidney cancer	1.25e-05	0.000162	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.23e-05	0.00016	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—IL2—kidney cancer	1.21e-05	0.000156	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PIK3CA—kidney cancer	1.16e-05	0.000151	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HIF1A—kidney cancer	1.15e-05	0.000149	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TSC2—kidney cancer	1.15e-05	0.000149	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—POMC—kidney cancer	1.12e-05	0.000145	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF2—kidney cancer	1.11e-05	0.000143	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CDKN2B—kidney cancer	1.1e-05	0.000143	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—KDR—kidney cancer	1.1e-05	0.000143	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF1R—kidney cancer	1.07e-05	0.000139	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—RAF1—kidney cancer	1.03e-05	0.000133	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—IL2—kidney cancer	1.02e-05	0.000132	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—KIT—kidney cancer	1.01e-05	0.000131	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—APC—kidney cancer	1.01e-05	0.000131	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PIK3CA—kidney cancer	9.82e-06	0.000127	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—MAPK3—kidney cancer	9.71e-06	0.000126	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—POMC—kidney cancer	9.65e-06	0.000125	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—BRAF—kidney cancer	9.53e-06	0.000123	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—IL2—kidney cancer	9.24e-06	0.00012	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—MAPK1—kidney cancer	9.24e-06	0.00012	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PTGS2—kidney cancer	8.94e-06	0.000116	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PIK3CA—kidney cancer	8.83e-06	0.000114	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HIF1A—kidney cancer	8.8e-06	0.000114	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TSC2—kidney cancer	8.78e-06	0.000114	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—KRAS—kidney cancer	8.72e-06	0.000113	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—KDR—kidney cancer	8.42e-06	0.000109	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PIK3CA—kidney cancer	8.02e-06	0.000104	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RAF1—kidney cancer	7.96e-06	0.000103	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RELA—kidney cancer	7.92e-06	0.000103	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ERBB2—kidney cancer	7.87e-06	0.000102	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PTEN—kidney cancer	7.79e-06	0.000101	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MTOR—kidney cancer	7.77e-06	0.000101	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—KIT—kidney cancer	7.76e-06	0.0001	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—APC—kidney cancer	7.76e-06	0.0001	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—MAPK3—kidney cancer	7.43e-06	9.62e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—POMC—kidney cancer	7.38e-06	9.56e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—BRAF—kidney cancer	7.29e-06	9.44e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CDKN1B—kidney cancer	7.29e-06	9.44e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IL2—kidney cancer	7.13e-06	9.24e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—MAPK1—kidney cancer	7.07e-06	9.16e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CCND1—kidney cancer	6.95e-06	9.01e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—JUN—kidney cancer	6.94e-06	8.99e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CTNNB1—kidney cancer	6.89e-06	8.92e-05	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	6.75e-06	8.75e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTEN—kidney cancer	6.71e-06	8.69e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—KRAS—kidney cancer	6.68e-06	8.65e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	6.13e-06	7.94e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RAF1—kidney cancer	6.09e-06	7.89e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—VEGFA—kidney cancer	6.06e-06	7.85e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RELA—kidney cancer	6.06e-06	7.85e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ERBB2—kidney cancer	6.02e-06	7.8e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MTOR—kidney cancer	5.94e-06	7.7e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MAPK3—kidney cancer	5.74e-06	7.43e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MYC—kidney cancer	5.58e-06	7.22e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CDKN1B—kidney cancer	5.58e-06	7.22e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PIK3CA—kidney cancer	5.5e-06	7.12e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IL2—kidney cancer	5.46e-06	7.07e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MAPK1—kidney cancer	5.46e-06	7.07e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CCND1—kidney cancer	5.32e-06	6.89e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—JUN—kidney cancer	5.31e-06	6.88e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CTNNB1—kidney cancer	5.27e-06	6.83e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—KRAS—kidney cancer	5.15e-06	6.68e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTEN—kidney cancer	5.14e-06	6.65e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PIK3CA—kidney cancer	4.74e-06	6.13e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—VEGFA—kidney cancer	4.64e-06	6.01e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TP53—kidney cancer	4.58e-06	5.93e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MAPK3—kidney cancer	4.39e-06	5.68e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MYC—kidney cancer	4.27e-06	5.53e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MAPK1—kidney cancer	4.18e-06	5.41e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—KRAS—kidney cancer	3.94e-06	5.11e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PIK3CA—kidney cancer	3.62e-06	4.69e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TP53—kidney cancer	3.51e-06	4.54e-05	CbGpPWpGaD
